Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Businessweek Archives

The Truth About Eyewash

Readers Report


In a perfectly normal world, your writer, Mark Maremont, might have entered a Boston retail outlet last week and found a 12-ounce container of Opti-Free Disinfecting Solution for $7.99 and two-thirds of an ounce of Opti-Free Rewetting Drops at $5.99. Instead, Maremont walked into his favorite store and found both products at $6.99. He then found a consultant who called this "sneaky marketing." Throw in a clever headline ("Eyeway robbery?" News: Analysis & Commentary, Feb. 27), and Maremont had exposed the rascals to the world.

The truth of the matter is that it costs roughly three-quarters as much, under stringent sterile-manufacturing requirements, to make the smaller bottle as it does the larger one. This is, in turn, properly reflected in our prices to the trade. The further truth is that many retailers discount the 12-ounce Opti-Free Disinfecting Solution because it is a high-volume seller and builds traffic. Sometimes, they also take a larger-than-normal margin on the slower-moving Rewetting Drops. Surely you are aware that these decisions are completely beyond the manufacturer's control.

E.H. Schollmaier

President & CEO

Alcon Laboratories Inc.

Fort Worth

blog comments powered by Disqus